secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALATIN TECHNOLOGIES INC (PTN)
CIK:        0000911216
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001654954-25-012641
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Palatin prices $15.8M public offering; NYSE American listing resumes Nov 12
---------------------------------------------------------------------------

- Priced upsized public offering of 2.43M shares at $6.50/unit; gross proceeds ~$15.8M.
- Series J warrants ($6.50) expire 31 days after FDA accepts IND for obesity program; Series K ($8.125) expire 5 years but terminate early if J not exercised.
- Underwriters granted 45-day option for additional 364,615 shares; closing expected Nov 12, 2025.
- Proceeds to fund obesity program and working capital; potential additional $15.8M upon cash exercise of Series J warrants.
- NYSE American listing resumes Nov 12 under PTN; compliance regained after reverse split and $8.8M revenue from Boehringer Ingelheim.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/911216/000165495425012641/0001654954-25-012641-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/911216/000165495425012641/ptn_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-012641

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer